OSE Immunotherapeutics met a jour l’information sur les procedures en cours

OSE Immunotherapeutics met a jour l'information sur les procedures en cours GlobeNewswire July 02, 2025 OSE Immunotherapeutics provides an update on ongoing proceedings NANTES, France, July 2, 2025, 8 AM – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announces that following the hearing on June 24th, 2025, the President of the Nantes Commercial Court rejected, […]

Caledonia Mining Corporation Plc Notification of relevant change to significant shareholder

Caledonia Mining Corporation Plc Notification of relevant change to significant shareholder GlobeNewswire July 02, 2025 ST HELIER, Jersey, July 02, 2025 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc (“Caledonia” or “the Company”) (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) announces that it received notification on June 30, 2025 from BlackRock, Inc. that on June 27,

Global Times: Practitioners’ Insights: How an academy educates Party members to ‘bring benefits to the people’ through legacy of grassroots model official Jiao Yulu

Center stage, a spotlight slowly descends, illuminating the figure of “Jiao Yulu.” Portrayed by Niu Haozhe, a young teacher, “Jiao” stands in faded, worn clothing, his deep gaze fixed on the audience below. “Who are you?… It's 2025? What will that look like? Will everyone be able to eat steamed buns made from fine flour?

STAMN Launches New ‘Nautis Residences’ Real Estate Development on Dubai Islands

— Prime residential project will feature just 63 limited-edition units, just 15 minutes from Dubai Downtown — STAMN has now invested more than AED 250 million into Dubai real estate communities STAMN Real Estate Development has announced the launch of Nautis Residences, a new prime residential project on Dubai Islands. The mid-rise development features 63

PR Newswire Expands Reach in Singapore via SPH Media Partnership

Collaboration unlocks premium visibility across Singapore's top news and finance platforms, empowering clients to engage broader audiences with greater impact. PR Newswire has partnered with SPH Media to significantly expand the reach of its clients' press release content within Singapore. This landmark collaboration provides unparalleled access for press releases sent via PR Newswire to two

PR Newswire Expands Reach in Singapore via SPH Media Partnership

Collaboration unlocks premium visibility across Singapore's top news and finance platforms, empowering clients to engage broader audiences with greater impact. PR Newswire has partnered with SPH Media to significantly expand the reach of its clients' press release content within Singapore. This landmark collaboration provides unparalleled access for press releases sent via PR Newswire to two

Expanding the Frontier of Device Management: Friendly Becomes prpl Foundation Member

NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) — Friendly Technologies, the leading provider of carrier-grade IoT and device management solutions, is proud to announce its official membership in the prpl Foundation, a collaborative community dedicated to open-source and open-standard development for next-generation connected devices. With a legacy of innovation in TR-069 and TR-369 protocol management,

Expanding the Frontier of Device Management: Friendly Becomes prpl Foundation Member

Expanding the Frontier of Device Management: Friendly Becomes prpl Foundation Member GlobeNewswire July 02, 2025 NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) — Friendly Technologies, the leading provider of carrier-grade IoT and device management solutions, is proud to announce its official membership in the prpl Foundation, a collaborative community dedicated to open-source and open-standard development

BioVersys and Shionogi Enter Into Global Research Collaboration For Broad-Spectrum Non-Tuberculous Mycobacteria (NTM) Clinical Candidate

Ad hoc announcement pursuant to Art. 53 LR BASEL, Switzerland, July 02, 2025 (GLOBE NEWSWIRE) — The Global Research Collaboration is a research and exclusive license option agreement with Shionogi to jointly develop novel ansamycin leads from BioVersys' BV500 program into clinical candidates Shionogi gets access to BioVersys' proprietary ansamycin platform and the BV500 program

BioVersys and Shionogi Enter Into Global Research Collaboration For Broad-Spectrum Non-Tuberculous Mycobacteria (NTM) Clinical Candidate

BioVersys and Shionogi Enter Into Global Research Collaboration For Broad-Spectrum Non-Tuberculous Mycobacteria (NTM) Clinical Candidate GlobeNewswire July 02, 2025 Ad hoc announcement pursuant to Art. 53 LR BASEL, Switzerland, July 02, 2025 (GLOBE NEWSWIRE) — The Global Research Collaboration is a research and exclusive license option agreement with Shionogi to jointly develop novel ansamycin leads

Scroll to Top